ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Pacira BioSciences, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 102 studies whose lead sponsor is Pacira BioSciences, Inc. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Pacira BioSciences with Jiangsu HengRui Medicine and IBSA Institut Biochimique →

Pipeline: 2 programs

Each counted once: 2 with a study Pacira BioSciences, Inc. leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Pacira BioSciences, Inc.’s own registered studies; Pacira BioSciences, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Pacira BioSciences, Inc.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Pacira BioSciences, Inc.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 102 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now33%
  • Under way, not recruiting22%
  • Completed7473%
  • Stopped early2222%Terminated 18 · Withdrawn 4
  • Status unknown or other11%

Phase

Where

  • United States91
  • Canada6
  • United Kingdom3
  • Poland3
  • Denmark3
  • Australia3

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 1812
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 4 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Pacira BioSciences, Inc.

  • Pacira Pharmaceuticals, Inc
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    102 studies

Focus areas

Conditions Pacira BioSciences, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 102. Browse all 102 →